Roche acquires Irish biotch Inflazome for €380m
Irish biotechnology firm Inflazome announced today that it has closed a share purchase agreement with Swiss pharma giant Roche in
Read more
Deals
Food allergy: Nestlé agrees $2.6bn acquisition of Aimmune Therapeutics
Nestlé’s nutritional science brand Nestlé Health Science (NHSc) furthers efforts of food allergy prevention through the acquisition of California-based biopharmaceutical
Read more
Merck to licence two preclinical immuno oncology programs from F-star
Two additional preclinical discovery programs will be added to the Merck KGaA and F-star Therapeutics collaboration. Merck KGaA, Darmstadt, Germany
Read more
Sanofi and GSK close to reaching $624 Million U.K. Vaccine Deal
Sanofi and GlaxoSmithKline are close to reaching a 500 million-pound ($624 million) deal to supply the United Kingdom government with
Read more
AstraZeneca to supply up to 400 million doses of Oxford’s vaccine free
AstraZeneca has come to an agreement with the European Inclusive Vaccines Alliance (IVA), initiated by Germany, France, Italy and the
Read more
AstraZeneca reaches $750m agreement with CEPI for Oxford COVID-19 vaccine
British pharmaceutical company AstraZeneca has reached a landmark $750 million agreement with Coalition for Epidemic Preparedness Innovation (CEPI) and the
Read more
Moderna and Lonza partner up to manufacture COVID-19 vaccine
Moderna, a clinical-stage biotech developing messenger RNA (mRNA) therapeutics and vaccines, and Swiss pharma giant Lonza today announced the introduction
Read more
AstraZeneca and Oxford University agree to globalise COVID-19 vaccine
UK-headquartered AstraZeneca and Oxford University announced an agreement to develop and distribute the university’s future recombinant adenovirus vaccine to prevent
Read more
Pharma giants Sanofi and GSK team up to develop COVID-19 vaccine
Pharma giants Sanofi and GSK have entered into an unprecedented partnership to battle COVID-19. The leading pharmaceutical companies have agreed
Read more
Dynavax and Clover to collaborate for Coronavirus (COVID-19) Vaccine
Dynavax and Clover Biopharmaceuticals have announced a research collaboration to evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant. US
Read more